SAT0590 Long-Term Efficacy and Safety of Adalimumab by Aetiologyin Patients With Non-Infectious Uveitis in the Visual Iii Trial

doi 10.1136/annrheumdis-2018-eular.2613
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

FRI0618 Adalimumab in Non-Infectious Uveitis – Efficacy Across Different Etiologies in the Visual I and Visual Ii Trials

2017English

Long-Term Safety of Adalimumab in Adult Patients With Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated With Juvenile Idiopathic Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2018English

Predictors of Long-Term Visual Outcome in Intermediate Uveitis

Ophthalmology
Ophthalmology
2017English

Efficacy of Adalimumab in a Patient With Juvenile Idiopathic Arthritis and Uveitis

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2012English

Long-Term Efficacy and Safety of Cardioneuroablation in Patients With Vagally Mediated Bradyarrhythmias

e-Journal of Cardiovascular Medicine
2020English

OP0021 Efficacy and Safety Results of a Phase Iii Study Comparing Fkb327, an Adalimumab Biosimilar, With the Adalimumab Reference Product in Patients With Active Rheumatoid Arthritis

2017English

Romiplostim Monotherapy in Thrombocytopenic Patients With Myelodysplastic Syndromes: Long-Term Safety and Efficacy

British Journal of Haematology
Hematology
2017English

Long-Term Safety of Adalimumab in Clinical Trials in Adult Patients With Crohn's Disease or Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy